Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Noxopharm Ltd V.NOX


Primary Symbol: NOXOF

Noxopharm Limited is a biotech company. It is engaged in discovering and developing novel treatments for cancer and inflammation, including a pioneering technology to enhance messenger ribonucleic acid (mRNA) vaccines. It utilizes specialist in-house capabilities and partnerships with researchers to build a pipeline of new proprietary drugs based on two technology platforms: Chroma (oncology) and Sofra (inflammation, autoimmunity, and mRNA vaccine enhancement). Chroma is a technology platform focused on the development of multiple drug candidates, primarily for cancer treatment. The Sofra technology platform has a pipeline of proprietary drugs based on oligonucleotides, the building blocks of deoxyribonucleic acid (DNA), with a focus on mRNA vaccines and the treatment of autoimmune and inflammatory diseases. SOF-VAC has applications in the treatment of excessive inflammatory responses associated with specialized inflammatory receptors in the body known as Toll-like receptor 7.


OTCPK:NOXOF - Post by User

Post by loonietuneson Aug 28, 2013 8:00pm
196 Views
Post# 21704906

According To Niogolds Radio Interview

According To Niogolds Radio InterviewThat was done in July so a month later it may have gone down-who knows the 560k is a back of the envelope calculation on the 1.6 mil expenditure if you follow BAR-it popped after they announced the receipt of their tax cheque.  From my view the jrs live and die by the drilling results until they start to produce after that even some of the best get no love!  You can't tell what will set off a run, my position is long but small-the volume today was more than yesterday but fewer actual trades occurred-I'm guessing we are being accumulated?  The only other interesting thing I noticed was 50k going to Leede(last hour)  and Merrill were also on the scene?  I'm merely an owner/observer of what will unfold.
<< Previous
Bullboard Posts
Next >>